Mono and Epstein-Barr Virus (EBV) Vaccine Study
Now Enrolling in Austin
Mono and EBV Investigational Vaccine Study
Tekton Research is looking for men and women (18-30) to participate in a clinical trial.
You may be eligible to take part if you:
- Are between 18-30 years of age.
- Are in good or stable health.
- Have not been exposed to someone with COVID-19 within 14 days of screening.
- Are not pregnant or breastfeeding.
What is Mono and EBV?
Infectious Mononucleosis (also known as mono) is often associated with Epstein-Barr Virus (EBV), which results in lifelong infection and the possibility of developing other diseases. 90% of people in the US get infected with EBV by age 35. Currently, there is no approved vaccine for EBV.
Why Tekton?
Tekton Research is a clinical research site that conducts clinical studies with the primary focus on improving the quality of life for all.
We work with pharmaceutical and device companies to help bring new and more effective medications to those who need them. We conduct studies with deliberate concentration on knowledge, skills and integrity.
Here at Tekton, our staff ensures that every potential and current study participant is accurately qualified for the most appropriate study based on criteria.
